Metraipolis › archive › dc_19cf431c0710

Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the… — Europe PMC PMID:42288801

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42288801
DOI
10.1186/s10194-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-31T12:25:01.947Z
SHA-256 of the archived text
03b8ed1cb5cb6dde732d0faefb63448c33756e4a31d12f1f30f045cfb38c1b9e
Stable URL of this page
https://metraipolis.com/documento/dc_19cf431c0710

How to cite

Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the… — Europe PMC PMID:42288801 — Europe PMC (en), https://europepmc.org/article/MED/42288801 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_19cf431c0710 (Metraipolis archive dc_19cf431c0710, sha256 03b8ed1cb5cb6dde732d0faefb63448c33756e4a31d12f1f30f045cfb38c1b9e)
BibTeX
@misc{dc19cf431c0710,
  title = {Efficacy and safety of eptinezumab in adults with chronic migraine and medication-overuse headache who also received patient education: 24-week results of the… — Europe PMC PMID:42288801},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42288801},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_19cf431c0710; sha256 03b8ed1cb5cb6dde732d0faefb63448c33756e4a31d12f1f30f045cfb38c1b9e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42288801. Agents can read the archived copy with the MCP tool read_document.